MacroGenics reported $1.53M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.66M 496K Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
J&J USD 2.12 0.17 Sep/2025
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Xencor USD 7.25M 290K Jun/2025